https://www.selleckchem.com/products/td139.html
We observe that MADE (1) is larger when the safety improvement for the experimental arm is larger, (2) depends on the association between the efficacy and safety outcomes, and (3) depends on the control arm efficacy rate. We use a numerical example for power comparisons between a superiority test for the composite outcome vs a noninferiority test for efficacy using the MADE as the NI margin, and apply the methods to a TB treatment trial.Four-stranded G-quadruplex (G4) DNA is a non-canonical DNA topology that has been proposed to form in c